Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT06302569 |
Title | Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma (REPRINT) |
Acronym | REPRINT |
Recruitment | Not yet recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Giuseppe Procopio |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | ITA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Fondazione Irccs Istituto Dei Tumori Di Milano | Milan | 20133 | Italy | Details |